The Impact of Long COVID on Global Public Health: Long-term Consequences and Healthcare System Preparedness
DOI:
https://doi.org/10.37899/mjdh.v1i2.74Keywords:
Long COVID, Healthcare Preparedness, Public HealthAbstract
Long COVID, or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), is an emerging global public health challenge. This study aims to quantitatively assess the prevalence, symptom profiles, and long-term consequences of Long COVID while evaluating the preparedness of healthcare systems to manage its impact. A cross-sectional analysis was conducted on 5,000 individuals from high-, middle-, and low-income regions who experienced COVID-19. Results show that 30% of participants reported persistent symptoms, with fatigue (60%), cognitive impairment (45%), and shortness of breath (40%) being the most common. Long COVID disproportionately affected older adults, females, and those with pre-existing conditions. Furthermore, 50% of patients reported an inability to return to work, highlighting the condition’s significant economic burden. Healthcare utilization was high, with 70% of patients requiring outpatient visits and 45% needing rehabilitation services. However, healthcare system preparedness was found to be inadequate, particularly in low-income countries, where only 40% of patients had access to necessary care. Specialized Long COVID clinics and rehabilitation programs were the most effective interventions, with 60% of patients reporting improvement. These findings underscore the urgent need for healthcare system reforms and targeted interventions to address the long-term impacts of Long COVID.
References
Adebanjo, A. T. (2024). Impact of COVID-19 on healthcare providers in Africa. In COVID-19 and the Right to Health in Africa (pp. 271-300). Routledge.
Al-Aly, Z., Xie, Y., Bowe, B. (2022). Long-term health outcomes of COVID-19. BMJ, 376, o114. https://doi.org/10.1136/bmj.o114
Alwan, N. A., Johnson, L. (2021). Defining long COVID: Going back to the start. Med, 2(5), 501-504. https://doi.org/10.1016/j.medj.2021.03.003
Amenta, E. M., Spallone, A., Rodriguez-Barradas, M. C., El Sahly, H. M., Atmar, R. L., Kulkarni, P. A. (2020). Postacute COVID-19: An overview and approach to classification. Open Forum Infectious Diseases, 7(12), ofaa509. https://doi.org/10.1093/ofid/ofaa509
Ashmawy, R., Hammouda, E. A., El-Maradny, Y. A., Aboelsaad, I., Hussein, M., Uversky, V. N., & Redwan, E. M. (2024). Interplay between comorbidities and long COVID: challenges and multidisciplinary approaches. Biomolecules, 14(7), 835. https://doi.org/10.3390/biom14070835
Bhala, N., Curry, G., Martineau, A. R., Agyemang, C., Bhopal, R. (2020). COVID-19: Ethnic and socioeconomic disparities in health. Lancet, 395(10239), 1675-1680. https://doi.org/10.1016/S0140-6736(20)30922-3
Carfi, A., Bernabei, R., Landi, F. (2020). Persistent symptoms in COVID-19 survivors. JAMA, 324(6), 603-605. https://doi.org/10.1001/jama.2020.12603
Cheng, A. L., Herman, E., Abramoff, B., Anderson, J. R., Azola, A., Baratta, J. M., ... & Niehaus, W. N. (2025). Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement. PM&R, 17(6), 684-708. https://doi.org/10.1002/pmrj.13397
Cutler, D. M. (2022). The economic cost of long COVID. JAMA Health Forum, 3(5), e221809. https://doi.org/10.1001/jamahealthforum.2022.1809
Davidson, J. A., & Warren-Gash, C. (2019). Cardiovascular complications of acute respiratory infections: current research and future directions. Expert review of anti-infective therapy, 17(12), 939-942.
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., Akrami, A. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine, 38, 101019.
Del Rio, C., Collins, L. F., Malani, P. (2020). Long-term health consequences of COVID-19. JAMA, 324(14), 1389-1391. https://doi.org/10.1001/jama.2020.19719
Effiong, A. (2022). Post-acute sequelae of COVID-19 and adverse psychiatric outcomes: an etiology and risk systematic review protocol. medRxiv, 2022-02. https://doi.org/10.2196/43880
Emami, S. G., Lorenzoni, V., & Turchetti, G. (2024). Towards resilient healthcare systems: a framework for crisis management. International journal of environmental research and public health, 21(3), 286.
Filip, R., Gheorghita Puscaselu, R., Anchidin-Norocel, L., Dimian, M., & Savage, W. K. (2022). Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems. Journal of personalized medicine, 12(8), 1295. https://doi.org/10.3390/jpm12081295
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., ... & Cao, B. (2021). RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The lancet, 397(10270), 220-232.
Jiang, D. H., Roy, D. J., Gu, B. J., Hassett, L. C., & McCoy, R. G. (2021). Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: a state-of-the-art review. Basic to Translational Science, 6(9-10), 796-811.
Jiao, T., Huang, Y., Sun, H., & Yang, L. (2024). Research progress of post-acute sequelae after SARS-CoV-2 infection. Cell Death & Disease, 15(4), 257. https://doi.org/10.1016/j.jacbts.2021.07.002
Laugsand, E. A., Sprangers, M. A., Bjordal, K., Skorpen, F., Kaasa, S., & Klepstad, P. (2010). Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health and quality of life outcomes, 8(1), 104. https://doi.org/10.1186/1477-7525-8-104
Mendelson, M., Nel, J., Blumberg, L., et al. (2021). Long COVID: An emerging public health concern. Lancet Respiratory Medicine, 9(7), 695-708. https://doi.org/10.1016/S2213-2600(21)00256-8
Rosendal, M., Olde Hartman, T. C., Aamland, A., Van der Horst, H., Lucassen, P., Budtz-Lilly, A., & Burton, C. (2017). “Medically unexplained” symptoms and symptom disorders in primary care: prognosis-based recognition and classification. BMC Family Practice, 18(1), 18. https://doi.org/10.1186/s12875-017-0592-6
Schultz, K. R., McGrath, S., Keary, T. A., Meng, C. K., Batchos, E., Evans, L., ... & Fornalski, N. (2024). A multidisciplinary approach to assessment and management of long COVID cognitive concerns. Life Sciences, 357, 123068. https://doi.org/10.1016/j.lfs.2024.123068
Stavem, K., Ghanima, W., Olsen, M. K., Gilboe, H. M., & Einvik, G. (2021). Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax, 76(4), 405-407. https://doi.org/10.1136/thoraxjnl-2020-216377
Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., Molteni, E., Modat, M., Jorge Cardoso, M., Wolf, J., Spector, T. D., Ourselin, S., Steves, C. J. (2021). Attributes and predictors of long COVID. Nature, 593, 437-441. https://doi.org/10.1038/s41591-021-01292-y
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., Harrison, P. J. (2021). Neurological and psychiatric risk after COVID-19. Lancet Psychiatry, 8(5), 416-427. https://doi.org/10.1016/S2215-0366(21)00084-5
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X. (2022). Therapeutic advancements in COVID-19 vaccines. Journal of Immunology, 14(3), 56-72. https://doi.org/10.1038/s41419-024-06642-5
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Magenta Journal De Healthymedi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This journal provides direct open access to it's content on the principle that research is freely available to the public supporting a greater global exchange of knowledge. All articles published by Open Access will soon and forever be free for everyone to read and download. The license options defined for this journal are Creative Commons Attribution-ShareAlike (CC BY-SA)
